Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Current Deferred Tax Assets (2020 - 2022)

Definitive Healthcare's Current Deferred Tax Assets history spans 3 years, with the latest figure at $8.5 million for Q2 2022.

  • For Q2 2022, Current Deferred Tax Assets changed N/A year-over-year to $8.5 million; the TTM value through Jun 2022 reached $8.5 million, changed N/A, while the annual FY2021 figure was $6.9 million, 133.46% up from the prior year.
  • Current Deferred Tax Assets reached $8.5 million in Q2 2022 per DH's latest filing, up from $7.7 million in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $8.5 million in Q2 2022 to a low of $2.9 million in Q4 2020.
  • Average Current Deferred Tax Assets over 3 years is $6.3 million, with a median of $6.9 million recorded in 2021.
  • The largest YoY upside for Current Deferred Tax Assets was 133.46% in 2021 against a maximum downside of 133.46% in 2021.
  • A 3-year view of Current Deferred Tax Assets shows it stood at $2.9 million in 2020, then surged by 133.46% to $6.9 million in 2021, then rose by 23.1% to $8.5 million in 2022.
  • Per Business Quant, the three most recent readings for DH's Current Deferred Tax Assets are $8.5 million (Q2 2022), $7.7 million (Q1 2022), and $6.9 million (Q4 2021).